Evaluation and treatment of chagas disease in the United States: A systematic review

JAMA

Volumn 298, Issue 18, 2007, Pages 2171-2181

  Bern, Caryn ^a   Montgomery, Susan P ^a   Herwaldt, Barbara L ^a   Rassi, Anis ^b   Marin Neto, Jose Antonio ^c   Dantas, Roberto O ^c   Maguire, James H ^d   Acquatella, Harry ^e   Morillo, Carlos ^f   Kirchhoff, Louis V ^g   Gilman, Robert H ^h   Reyes, Pedro A ⁱ   Salvatella, Roberto ^j   Moore, Anne C ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Anis Rassi Hospital   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF MARYLAND   (United States)

^e UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF IOWA   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^j PAN AMERICAN HEALTH ORGANIZATION   (Uruguay)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BARIUM; BENZNIDAZOLE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFURTIMOX;

ABDOMINAL DISCOMFORT; ANAMNESIS; ANOREXIA; BONE MARROW SUPPRESSION; CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL TRIAL; COLIC; CONGENITAL DISORDER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DECISION MAKING; DEFIBRILLATION; DERMATITIS; DISEASE COURSE; DISORIENTATION; DIZZINESS; DYSGEUSIA; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; EVIDENCE BASED MEDICINE; EXERCISE TEST; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; MACULOPAPULAR RASH; MEDLINE; MOOD CHANGE; NAUSEA; NERVE EXCITABILITY; NEURITIS; ORGAN TRANSPLANTATION; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; RASH; REVIEW; SIDE EFFECT; SKIN ALLERGY; SYSTEMATIC REVIEW; TREMOR; UNITED STATES; VERTIGO; VOMITING; WEIGHT REDUCTION;

EID: 36148997207     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.18.2171     Document Type: Review

References (102)

1. Maguire JH. Trypanosoma. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004: 2327-2334.
2. Magill AJ, Reed SG. American trypanosomiasis. In: Strickland GT, ed. Hunter's Tropical Medicine and Emerging Diseases. 8th ed. Philadelphia, PA: WB Saunders Co; 2000:653-664.
3. Benchimol Barbosa PR. The oral transmission of Chagas' disease: an acute form of infection responsible for regional outbreaks. Int J Cardiol. 2006;112(1):132-133.
4. Organizacion Panamericana de la Salud. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: Organizacion Panamericana de la Salud; 2006.
5. Remme JHF, Feenstra P, Lever PR, et al. Tropical diseases targeted for elimination: Chagas disease, lymphatic filariasis, onchocerciasis, and leprosy. In: Jamison DT, Breman JG, Measham AR, et al, eds. Disease Control Priorities in Developing Countries. New York, NY: The World Bank and Oxford University Press; 2006: 433-449.
6. Regional PAHO Regional Program on Chagas Disease. Pan American Health Organization Web site. http://www.paho.org/english/ad/dpc/cd/dch-program-page. htm. Accessed July 1, 2007.
7. Kirchhoff LV. Changing epidemiology and approaches to therapy for Chagas disease. Curr Infect Dis Rep. 2003;5(1):59-65.
8. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion. 2002;42(5):549-555.
9. Bradley KK, Bergman DK, Woods JP, Crutcher JM, Kirchhoff LV. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J Am Vet Med Assoc. 2000;217(12):1853-1857.
10. Pung OJ, Banks CW, Jones DN, Krissinger MW. Trypanosoma cruzi in wild raccoons, opossums, and triatomine bugs in southeast Georgia, U.S.A. J Parasitol. 1995;81(2):324-326.
11. Herwaldt BL, Grijalva MJ, Newsome AL, et al. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis. 2000;181(1):395-399.
12. Dorn PL, Perniciaro L, Yabsley MJ, et al. Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis. 2007;13(4):605-607.
13. Centers for Disease Control and Prevention. Blood donor screening for Chagas disease - United States, 2006-2007. MMWR Morb Mortal Wkly Rep. 2007;56(7):141-143.
14. Chagas' Biovigilance Network. AABB Web site. http://www.aabb.org/Content/ Programs_and_Services/Data_Center/Chagas/. Accessed September 12, 2007.
15. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115(9):1101-1108.
16. Rassi A Jr, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol. 2000;23(12):883-889.
17. Hagar JM, Rahimtoola SH. Chagas' heart disease. Curr Probl Cardiol. 1995;20(12):825-924.
18. de Oliveira RB, Troncon LE, Dantas RO, Menghelli UG. Gastrointestinal manifestations of Chagas' disease. Am J Gastroenterol. 1998;93(6):884-889.
19. Gascón J, Albajar P, Canas E, et al. Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic [in Spanish]. Rev Esp Cardiol. 2007;60(3):285-293.
20. Ministério da Saúde Brasil. Brazilian Consensus on Chagas disease [in Portuguese]. Rev Soc Bras Med Trop. 2005;38(suppl 3):7-29.
21. Sociedad Argentina de Cardiología. Consejo de Enfermedad de Chagas. Rev Argent Cardiol. 2002;70(suppl 1):1-87.
22. Pinto Dias JC. Natural history of Chagas' disease. Arq Bras Cardiol. 1995;65(4):359-366.
23. Maguire JH, Hoff R, Sherlock I, et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75(6):1140-1145.
24. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109-1123.
25. Kuschnir E, Sgammini H, Castro R, Evequoz C, Ledesma R, Brunetto J. Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy [in Spanish]. Arq Bras Cardiol. 1985;45(4):249-256.
26. Carrasco HA, Barboza JS, Inglessis G, Fuenmayor A, Molina C. Left ventricular cineangiography in Chagas' disease: detection of early myocardial damage. Am Heart J. 1982;104(3):595-602.
27. Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115(9):1124-1131.
28. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2005;46(6):e1-e82.
29. de Rezende JM, Moreira H. Chagasic megaesophagus and megacolon: historical review and present concepts. Arq Gastroenterol. 1988;25(special issue): 32-43.
30. Mota E, Todd CW, Maguire JH, et al. Megaesophagus and seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil. Am J Trop Med Hyg. 1984;33(5):820-826.
31. de Oliveira RB, Rezende Filho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas' disease. Am J Gastroenterol. 1995;90(7):1119-1124.
32. Atías A. A case of congenital chagasic megaesophagus: evolution until death caused by esophageal neoplasm, at 27 years of age [in Spanish]. Rev Med Chil. 1994;122(3):319-322.
33. Brücher BL, Stein HJ, Bartels H, Feussner H, Siewert JR. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg. 2001;25(6):745-749.
34. Miles MA, Feliciangeli MD, de Arias AR. American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies. BMJ. 2003;326(7404):1444-1448.
35. Campbell DA, Westenberger SJ, Sturm NR. The determinants of Chagas disease: connecting parasite and host genetics. Curr Mol Med. 2004;4(6):549-562.
36. Bittencourt AL. Congenital Chagas disease. Am J Dis Child. 1976;130(1):97-103.
37. Torrico F, Alonso-Vega C, Suarez E, et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg. 2004;70(2):201-209.
38. Bocchi EA, Bellotti G, Mocelin AO, et al. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg. 1996;61(6):1727-1733.
39. Fiorelli AI, Stolf NA, Honorato R, et al. Later evolution after cardiac transplantation in Chagas' disease. Transplant Proc. 2005;37(6):2793- 2798.
40. Maldonado C, Albano S, Vettorazzi L, et al. Using polymerase chain reaction in early diagnosis of reactivated Trypanosoma cruzi infection after heart transplantation. J Heart Lung Transplant. 2004;23(12):1345-1348.
41. Riarte A, Luna C, Sabatiello R, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999;29(3):561-567.
42. Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005;36(2):123-129.
43. Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol. 2007;101(1):31-50.
44. Vaidian AK, Weiss LM, Tanowitz HB. Chagas' disease and AIDS. Kinetoplastid Biol Dis. 2004;3(1):2.
45. Wegner DH, Rohwedder RW. The effect of nifurtimox in acute Chagas' infection. Arzneimittelforschung. 1972;22(9):1624-1635.
46. Kirchhoff LV. American trypanosomiasis (Chagas disease). In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens and Practice. 2nd ed. New York, NY: Churchill Livingstone; 2006:1082-1094.
47. WHO Expert Committee. Control of Chagas Disease. Brasilia, Brazil: World Health Organization; 2002. WHO technical report series 905.
48. Castro AM, Luquetti AO, Rassi A, Rassi GG, Chiari E, Galvao LM. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res. 2002;88(10):894-900.
49. Freilij H, Altcheh J. Congenital Chagas' disease: diagnostic and clinical aspects. Clin Infect Dis. 1995;21(3):551-555.
50. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev Soc Bras Med Trop. 2003;36(6):767-771.
51. Miles MA. American trypanosomiasis (Chagas disease). In: Cook GC, Zumla AI, eds. Manson's Tropical Disease. London, England: Elsevier Science Limited; 2003:1325-1335.
52. Andersson J, Orn A, Sunnemark D. Chronic murine Chagas' disease: the impact of host and parasite genotypes. Immunol Lett. 2003;86(2):207-212.
53. Bustamante JM, Rivarola HW, Fernandez AR, et al. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy. Clin Sci (Lond). 2003;104(4):415-420.
54. Laucella SA, Postan M, Martin D, et al. Frequency of interferon-gamma- producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis. 2004;189(5):909-918.
55. Acquatella H, Catalioti F, Gomez-Mancebo JR, Davalos V, Villalobos L. Long-term control of Chagas disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities, and clinical outcome. Circulation. 1987;76(3):556-562.
56. Carrasco HA, Parada H, Guerrero L, Duque M, Duran D, Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int J Cardiol. 1994;43(1):27-38.
57. Acquatella H, Schiller NB, Puigbo JJ, et al. M-mode and two-dimensional echocardiography in chronic Chagas heart disease: a clinical and pathologic study. Circulation. 1980;62(4):787-799.
58. Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, Simoes MV, Maciel BC. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int J Cardiol. 1998;65(3):261-269.
59. Pazin-Filho A, Romano MM, Almeida-Filho OC, et al. Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res. 2006;39(4):483-487.
60. Viotti R, Vigliano C, Lococo B, et al. Clinical predictors of chronic chagasic myocarditis progression [in Spanish]. Rev Esp Cardiol. 2005;58(9):1037-1044.
61. Viotti R, Vigliano C, Lococo B, et al. Exercise stress testing as a predictor of progression of early chronic Chagas heart disease. Heart. 2006;92(3):403-404.
62. Viotti RJ, Vigliano C, Laucella S, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart. 2004;90(6):655-660.
63. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355(8):799-808.
64. Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation. 1994;90(6):3098-3102.
65. Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study. Circulation. 2003;108(3):305-312.
66. Carod-Artal FJ. Chagas cardiomyopathy and ischemic stroke. Expert Rev Cardiovasc Ther. 2006;4(1):119-130.
67. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol. 2001;76(1):75-96.
68. Bocchi EA, Fiorelli A; First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann Thorac Surg. 2001;71(6):1833-1838.
69. Castro C. Longitudinal radiological study of the esophagus in Chagas disease. Mem Inst Oswaldo Cruz. 1999;94(suppl 1):329-330.
70. Castro C, Macedo V, Rezende JM, Prata A. Longitudinal radiologic study of the esophagus, in an endemic area of Chagas disease, in a period of 13 years [in Portuguese]. Rev Soc Bras Med Trop. 1994;27(4):227-233.
71. Maguire JH, Mott KE, Souza JA, Almeida EC, Ramos NB, Guimaraes AC. Electrocardiographic classification and abbreviated lead system for population-based studies of Chagas' disease. Bull Pan Am Health Organ. 1982;16(1):47-58.
72. Lázzari JO, Pereira M, Antunes CM, et al. Diagnostic electrocardiography in epidemiological studies of Chagas' disease: multicenter evaluation of a standardized method. Rev Panam Salud Publica. 1998;4(5):317-330.
73. Maguire JH, Mott KE, Lehman JS, et al. Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil. Am Heart J. 1983;105(2):287-294.
74. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Boston, MA: John Wright; 1982.
75. Marin-Neto JA, Marzullo P, Marcassa C, et al. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am J Cardiol. 1992;69(8):780-784.
76. Simões MV, Dantas RO, Ejima FH, Meneghelli UG, Maciel BC, Marin-Neto JA. Esophageal origin of precordial pain in chagasic patients with normal subepicardial coronary arteries [in Portuguese]. Arq Bras Cardiol. 1995;64(2):103-108.
77. Meneghelli UG, Peria FM, Darezzo FM, et al. Clinical, radiographic, and manometric evolution of esophageal involvement by Chagas' disease. Dysphagia. 2005;20(1):40-45.
78. Dantas RO. Dysphagia in patients with Chagas' disease. Dysphagia. 1998;13(1):53-57.
79. Dantas RO, Deghaide NH, Donadi EA. Esophageal manometric and radiologic findings in asymptomatic subjects with Chagas' disease. J Clin Gastroenterol. 1999;28(3):245-248.
80. Rodriques Coura J, deCastro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002;97(1):3-24.
81. Ferreira RCC, Ferreira LCS. Mutagenicity of nifurtimox and benznidazole in the Salmonella microsoma assay. Braz J Med Biol Res. 1986;19(1):19-25.
82. Gorla NB, Ledesma OS, Barbieri GP, Larripa IB. Thirteenfold increase of chromosomal aberrations nonrandomly distributed in chagasic children treated with nifurtimox. Mutat Res. 1989;224(2):263-267.
83. Teixeira AR, Cordoba JC, Souto Maior I, Solorzano E. Chagas' disease: lymphoma growth in rabbits treated with benznidazole. Am J Trop Med Hyg. 1990;43(2):146-158.
84. Teixeira AR, Silva R, Cunha Neto E, Santana JM, Rizzo LV. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. J Comp Pathol. 1990;103(1):37-48.
85. Bocchi EA, Higuchi ML, Vieira ML, et al. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease. J Heart Lung Transplant. 1998;17(4):399-405.
86. Kirchhoff LV. Chagas disease: American trypanosomiasis. Infect Dis Clin North Am. 1993;7(3):487-502.
87. de Andrade AL, Zicker F, de Oliveira RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet. 1996;348(9039):1407-1413.
88. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg. 1998;59(4):526-529.
89. Coura JR, de Abreu LL, Willcox HP, Petana W. Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission, I: preliminary evaluation [in Portuguese]. Rev Soc Bras Med Trop. 1997;30(2):139-144.
90. Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144(10):724-734.
91. Cancado JR, Brener Z. Terapeutica. In: Brener Z, Andrade Z, eds. Trypanosoma cruzi e doenca de Chagas. Rio de Janeiro, Brazil: Guanabara Koogan; 1979:362-424.
92. Altcheh J, Biancardi M, Lapena A, Ballering G, Freilij H. Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutíerrez, Buenos Aires, Argentina [in Spanish]. Rev Soc Bras Med Trop. 2005;38(suppl 2):41-45.
93. Rassi A, Ferreira HO. Tentativas de tratmento especifico da fase aguda da doenca de Chagas com nifurtimox em esquema de duracao prolongada. Rev Soc Bras Med Trop. 1971;5:235-262.
94. Boainain E. Tratamento etiologico da doenca de Chagas na fase cronica. Rev Goiania Med. 1979;25:1-60.
95. Camandaroba EL, Reis EA, Goncalves MS, Reis MG, Andrade SG. Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain. Rev Soc Bras Med Trop. 2003;36(2):201-209.
96. Veloso VM, Carneiro CM, Toledo MJ, et al. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Mem Inst Oswaldo Cruz. 2001;96(7):1005-1011.
97. Russomando G, de Tomassone MM, de Guillen I, et al. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg. 1998;59(3):487-491.
98. Sosa-Estani S, Segura EL. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr Opin Infect Dis. 2006;19(6):583-587.
99. The BENEFIT trial: evaluation of the use of an antiparasital drug (benznidazole) in the treatment of chronic Chagas' disease. http:// clinicaltrials.gov/show/NCT00123916. Accessibility verified October 11, 2007.
100. Gross PA, Barrett TL, Dellinger EP, et al; Infectious Diseases Society of America. Purpose of quality standards for infectious diseases. Clin Infect Dis. 1994;18(3):421.
101. Estani SS, Segura EL. Treatment of Trypanosoma cruzi infection in the undetermined phase: experience and current guidelines of treatment in Argentina. Mem Inst Oswaldo Cruz. 1999;94(suppl 1):363-365.
102. Rassi A, Luquetti AO. Specific treatment for Trypanosoma cruzi infection (Chagas disease). In: Tyler KM, Miles MA, eds. American Trypanosomiasis. Boston, MA: Kluwer Academic Publishers; 2003:117-125.